The showdown between Taysha Gene Therapies (NASDAQ: TSHA) and GlobeImmune, Inc. (OTCMKTS: GBIM) pits two very different biotech equity stories against each other. Taysha is an active clinical-stage gene therapy developer focused...
Category - Hot Stocks
Fed Chatter Keeps Markets Tight, Renewables Shine
Opening Recap Market Pulse: Markets edged within a tight range as central-bank chatter dominated trading and traders held back before fresh catalysts. Key Movers: Renewables and banks stole the spotlight—Mirae Asset’s ramp-up in...
GEO: Why insiders are betting big on prison real estate!
Introduction The GEO Group (NYSE: GEO) is a major private prison and detention center operator that has drawn renewed attention from insiders. In recent months, GEO’s leadership has been accumulating shares – a vote of confidence...
Janney’s Rebalancing Sparks Major Market Rotation
Market Pulse: Equities drifted as Janney Montgomery Scott’s rebalancing rippled through software and banking circles. Traders are parsing the firm’s buy and sell signals for early rotation clues. Key Movers: Janney’s new stakes...
MNPR: $86.22 Price Target Sparks Investment Buzz!
Company Overview & Recent Surge Monopar Therapeutics Inc. (NASDAQ: MNPR) is a clinical-stage biopharmaceutical company developing treatments for cancer and rare diseases. Its lead asset, ALXN1840, is a copper-binding drug in...
Insider Buying Sparks Weekend Market Rally
Weekend Market Snapshot Market Pulse: Tech earnings chatter and heavy insider purchases sent S4 Capital stock into overdrive, lifting U.K. digital services sentiment after last week’s lull. Key Movers: Insider buying at S4...
“Why TSI’s unique strategy could redefine your portfolio!”
Introduction TCW Strategic Income Fund (TSI) is a closed-end fund that takes an unconventional multi-asset approach to generate income and capital appreciation. Managed by TCW since 1987, TSI invests flexibly across a broad range...
Gold Stocks Outpace AI Rally with 135% Surge
Morning Market Recap Market Pulse: Precious-metals miners have stormed ahead of broader markets, with gold equities posting a 135% gain in 2025, overshadowing chip names stuck in a funk. Key Movers: See “Gold Stocks Trounce AI...
“KALA: Mizuho Downgrade Sparks Hidden Opportunity!”
Introduction Kala Bio, Inc. (NASDAQ: KALA) – formerly Kala Pharmaceuticals – is a clinical-stage biotech focused on rare ocular diseases. The company’s stock plummeted ~90% in late September 2025 after announcing that its lead...
Ohio Pension’s Tech Bet Signals Market Rotation
Opening Recap Market Pulse: Yesterday’s institutional moves nudged select cyclicals and tech into the spotlight, leaving the broader indices in a mixed grip. Key Movers: Ohio’s pension fund snapped up stakes in AST SpaceMobile...